コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 response to HCV antigens were enumerated by Enzyme Linked Immunospot Assay.
2 body assay, and an interferon gamma-specific enzyme-linked immunospot assay.
3 producing B cells could still be detected by enzyme-linked immunospot assay.
4 5, 7, and 14 postgrafting, as measured by an enzyme-linked immunospot assay.
5 +) T lymphocytes were induced as analyzed by enzyme-linked immunospot assay.
6 h nodes, lungs, and Peyer's patches using an enzyme-linked immunospot assay.
7 -positive, HLA A2-positive individuals in an enzyme-linked immunospot assay.
8 pond to HIV-1 peptides in a gamma interferon enzyme-linked immunospot assay.
9 T-cell responses by using a gamma interferon enzyme-linked immunospot assay.
10 ed in the various tissues of GalT-/- mice by enzyme-linked immunospot assay.
11 mic lymphoid tissues were evaluated using an enzyme-linked immunospot assay.
12 -seropositive individual using the IFN-gamma enzyme-linked immunospot assay.
13 ction in tear IgA induction, was measured by enzyme-linked immunospot assay.
14 t assay and lung antibody secreting cells by enzyme-linked immunospot assay.
15 body- forming cells were determined using an enzyme-linked immunospot assay.
16 cells measured before challenge by cultured enzyme-linked immunospot assay.
17 and dsDNA antibody-secreting cells (ASCs) by enzyme-linked immunospot assay.
18 ral suppression assay (VSA) and an IFN-gamma enzyme-linked immunospot assay.
19 red by enzyme-linked immunosorbent assay and enzyme-linked immunospot assay.
20 us peptides via interferon-gamma (IFN-gamma) enzyme-linked immunospot assay.
21 s were detected by gamma interferon-specific enzyme-linked immunospot assay.
22 B cell Ig isotype switching was measured by enzyme-linked immunospot assay.
23 tibody-secreting cells were enumerated using enzyme-linked immunospot assay.
24 assays, intracelluar cytokine staining, and enzyme-linked immunospot assay.
25 l responses were assayed by interferon-gamma enzyme-linked immunospot assay.
26 ymphocyte proliferation and interferon gamma enzyme-linked immunospot assay.
27 racheobronchial lymph nodes as determined by enzyme-linked immunospot assay.
28 and in 22 (73%) of 30 vaccine recipients by enzyme-linked immunospot assay.
29 emory responses were evaluated by IFN- gamma enzyme-linked immunospot assay.
30 ulated memory B cells were detected using an enzyme-linked immunospot assay.
31 red in peripheral blood mononuclear cells by enzyme-linked immunospot assay.
32 , and IL-6 cytokines as measured by cytokine enzyme-linked immunospot assay.
33 producing gamma interferon when analyzed by enzyme-linked immunospot assay.
34 T-cell responses as measured using IFN-gamma enzyme-linked immunospot assays.
35 DNA cells by IFN-gamma-secretion measured in enzyme-linked immunospot assays.
36 ls in both cytotoxicity assays and IFN-gamma enzyme-linked immunospot assays.
37 the lamina propria of the small intestine by enzyme-linked immunospot assays.
38 lected at selected times were quantitated by enzyme-linked immunospot assays.
39 (spleen and blood) lymphoid tissues by using enzyme-linked immunospot assays.
40 cell responses, measured by interferon gamma enzyme-linked immunospot assays.
41 wild-type sequence was also demonstrated by enzyme-linked immunospot assays.
42 A-matched peptides by using gamma interferon enzyme-linked immunospot assays.
43 aining, and fine mapping in interferon-gamma enzyme-linked immunospot assays.
44 pol regimen, as measured by gamma interferon enzyme-linked immunospot assays.
45 ysis), and more IFN-gamma-secreting cells by enzyme-linked immunospot assay (1460 vs 280 IFN-gamma sp
46 ted in these animals by the gamma interferon enzyme-linked immunospot assay against pools of short ov
47 specific CD8+ CTL responses were detected by enzyme-linked immunospot assay against several NY-BR-1 p
48 mune responses were measured by tetramer and enzyme-linked immunospot assays against gp100 and MART-1
49 e compared by standardized interferon- gamma enzyme-linked immunospot assays among 250 unvaccinated i
51 lar sensitization was detected by performing enzyme-linked immunospot assay analysis for cytokines in
52 ce data of specific genes were combined with enzyme-linked immunospot assay analysis of critical epit
54 rus-specific T-cell responses by means of an enzyme-linked immunospot assay and antibody responses by
55 A antibody-secreting B cells was analyzed by enzyme-linked immunospot assay and by analysis of Epstei
57 (+) T cells, as detected by interferon gamma enzyme-linked immunospot assay and flow cytometry, were
60 ion assay) and T cell responses (measured by enzyme-linked immunospot assay and intracellular cytokin
62 ain SCC-derived antigens using the IFN-gamma enzyme-linked immunospot assay and intratumor (IT) and c
63 at multiple time points by interferon-gamma enzyme-linked immunospot assay and was correlated to the
64 this limitation by using two-color cytokine enzyme-linked immunospot assays and computer-assisted im
65 or cell readout assays (such as the cytokine enzyme-linked immunospot assay) and MS to identify relev
66 mined by intracellular cytokine staining and enzyme-linked immunospot assay) and produced anti-PR8 an
67 ss I Gag-tetramer staining, gamma interferon-enzyme-linked immunospot assay, and cytotoxic T-cell ass
68 ays, antigen-specific interferon (IFN)-gamma enzyme-linked immunospot assay, and enzyme-linked immuno
69 ern blot, delayed type hypersensitivity, and enzyme-linked immunospot assay, and reduced the number o
70 tified memory responses measured by cultured enzyme-linked immunospot assay as well as in vitro inter
71 e measured in 9 patients by interferon-gamma enzyme-linked immunospot assay at 3 time points within 1
72 in the blood by gamma interferon (IFN-gamma) enzyme-linked immunospot assay at select time points; ho
73 re likely to have a positive response to ASC enzyme-linked immunospot assay at the late time point th
74 a virus were detected by an interferon gamma enzyme-linked immunospot assay but had no clear relation
75 analyzed in the gamma interferon (IFN-gamma)-enzyme-linked immunospot assay by using synthetic overla
76 f CNS-derived mononuclear cells by IFN-gamma enzyme-linked immunospot assay confirmed the selection o
79 d multiparameter flow cytometric sorting and enzyme-linked immunospot assay, demonstrate that anti-Ga
81 s from MAN and/or MPL-treated mice, using an enzyme-linked immunospot assay designed to detect indivi
82 1 subject, antigen-specific interferon-gamma enzyme-linked immunospot assay detected an immunogenic d
85 ific T cells, enumerated by gamma interferon enzyme-linked immunospot assay, did not appear until 2 w
86 ls developed neutralizing antibodies and low enzyme-linked immunospot assay (E-SPOT) titers against S
88 ssed by ex vivo gamma interferon (IFN-gamma) enzyme-linked immunospot assay (ELISPOT) and antibody as
89 to detect autoreactive responses when using enzyme-linked immunospot assay (ELISPOT) and enzyme-link
90 LSA-1 and TRAP peptides were assessed by the enzyme-linked immunospot assay (ELISPOT) and enzyme-link
91 ere detected by interferon-gamma (IFN-gamma) enzyme-linked immunospot assay (ELISPOT) assays using th
92 Gamma interferon (IFN-gamma) measured by enzyme-linked immunospot assay (ELISPOT) at multiple tim
93 racellular IFN-gamma staining, and IFN-gamma enzyme-linked immunospot assay (ELISPOT) indicated that
98 ent assays (ELISA) titers, and EnvA-specific enzyme-linked immunospot assays (ELISPOT) responses.
99 tion, and measured antibody-secreting cells (enzyme-linked immunospot assay [ELISPOT]) as an early ma
100 phisms with cellular (interferon [IFN] gamma enzyme-linked immunospot assay [ELISPOT]) immune respons
101 in humans before transplantation, we used an enzyme-linked immunospot assay for detection of allospec
102 e further confirmed by the results of CD4(+) enzyme-linked immunospot assay for interferon (IFN)-gamm
103 ng was performed using a CEA peptide and the enzyme-linked immunospot assay for interferon gamma prod
105 cluding MHC class I tetramer binding assays, enzyme-linked immunospot assays for IFN-gamma production
106 cells that recognize EBV-latent antigens in enzyme-linked immunospot assays for interferon gamma sec
107 BL/6 beta-gal transgenic skin were tested in enzyme-linked immunospot assays for recall responses to
109 us cytokine production by MLN cells using an enzyme-linked immunospot assay, immunohistochemistry, an
110 , and GAD65 peptides) were measured by IL-17 enzyme-linked immunospot assay in patients with new-onse
111 berculosis strain H37Rv as a stimulant in an enzyme-linked immunospot assay in sensitized individuals
112 ), and in healthy control subjects (n=10) by enzyme-linked immunospot assay in the presence and absen
113 c CD8(+)-T-cell responses were determined by enzyme-linked immunospot assays in 150 HIV-infected indi
114 ti-Gal-producing B cells was demonstrated by enzyme-linked immunospot assays in mixed KO + WT --> KO
115 s shown by cytotoxicity and interferon gamma enzyme-linked immunospot assays in six of nine patients.
117 ength of the allospecific immune response by enzyme-linked immunospot assay may allow improved pairin
118 immune-sensitization using the B and T-cell enzyme-linked immunospot assays may identify CMV-sensiti
119 eins were used to screen 15 normal donors in enzyme-linked immunospot assays of gamma interferon rele
120 pping peptides and gamma interferon-specific enzyme-linked immunospot assays of peripheral blood mono
123 were assessed using interferon (IFN)- gamma enzyme-linked immunospot assays on peripheral blood mono
124 validation cohort were measured by IFN-gamma enzyme-linked immunospot assay or intracellular cytokine
127 ed a 10- to 40-fold increase in HIV-specific enzyme-linked immunospot assay responses compared to tho
128 mmunosorbent assay titers, and EnvA-specific enzyme-linked immunospot assay responses, and these resp
131 mmunity to SHIV89.6 peptides was measured by enzyme-linked immunospot assay; strong responses to Gag
132 y higher numbers of spot-forming cells in an enzyme-linked immunospot assay than did T cells primed w
133 y-secreting cells (ASC) in blood measured by enzyme-linked immunospot assay, the antibody in lymphocy
135 s, trans-vivo delayed-type hypersensitivity, enzyme-linked immunospot assays, the use of antigen rece
136 t gamma interferon production, determined by enzyme-linked immunospot assay to at least one of the th
139 1 transgenic NOD mice in an interferon-gamma enzyme-linked immunospot assay to identify autoantigenic
140 D8 T cell responses were quantified using an enzyme-linked immunospot assay to measure interferon-gam
141 MI responses by interferon gamma (IFN-gamma) enzyme-linked immunospot assay using 3 recombinant HCV p
142 eens of immunized mice by a gamma interferon enzyme-linked immunospot assay using peptides derived fr
144 s-specific CD4 responses by gamma interferon enzyme-linked immunospot assay, using 410 overlapping pe
146 ic T cells were measured by interferon-gamma enzyme-linked immunospot assays, using recombinant vacci
147 gamma interferon-producing cells detected by enzyme-linked immunospot assay was increased (P < 0.01 f
150 assay and/or ex vivo interferon (IFN)-gamma enzyme-linked immunospot assay, was documented in 45.5%
154 asured by gamma interferon and interleukin 2 enzyme-linked immunospot assay were significantly higher
157 a interferon-secreting cells, as detected by enzyme-linked immunospot assay, were obtained in respons
158 cing CD4(+) T cell responses, as assessed by enzyme-linked immunospot assay, were significantly more
159 )-4-secreting cells were determined using an enzyme-linked immunospot assay, which demonstrated that
160 MPO-specific T cells were quantified by enzyme-linked immunospot assay with additional Treg cell
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。